Hasil Pencarian

Artikel


Undoing the Trap of Imported Pharmaceutical Raw Materials

If phytopharmaceuticals are developed more seriously, including market certainty, good prospects lie ahead for Indonesia to be able to reduce dependence on imported BBO or finished pharmaceutical products. President Joko Widodo is irked by Indonesia’s huge dependence on imports for drugs, pharmaceutical raw materials, and medical equipment. He wants to not just reduce the imports, but stop them altogether. "Speaking about health equipment, drugs and raw materials for medicines, we have to stop importing these items. We must produce them ourselves in our [own] country," the President said on 27 Dec. 2021 at the groundbreaking ceremony for the Bali International Hospital in Denpasar. Of course, we must support this good intention, but apart from medical equipment, do we have the capacity to stop importing raw materials for manufacturing drugs? Can we rely on our upstream pharmaceutical industry?

Mengurai Jerat Impor Bahan Baku Obat

Indonesia dikenal sebagai negara nomor dua di dunia dengan keragaman biodiversitas, setelah Brasil. Sayang industri fitofarmaka kita masih ketinggalan sejak dari R&D, infrastruktur industrinya, dan regulasi pendukungnya. Presiden Joko Widodo merasa terusik dengan besarnya ketergantungan pada impor obat, bahan baku obat dan alat kesehatan. Presiden ingin bukan sekadar mengurangi, tetapi tujuan nantinya adalah menghentikan impor. “Alkes, obat-obatan dan bahan baku obat, kita harus berhenti untuk mengimpor barang barang itu lagi. Kita produksi sendiri di negara kita,” kata Presiden saat peletakan batu pertama RS Internasional di Denpasar, Bali (27/12/2021). Tekad bagus ini tentu harus kita dukung, tetapi di samping alat kesehatan (alkes), apa bisa menghentikan impor bahan baku obat? Siapkah industri hulu farmasi kita?

Controlling Corona Vaccination Effect in Chronic Kidney Disease Patients

To build herd immunity against corona or Covid-19, vulnerable groups, both because of age and health conditions, are prioritized in vaccination. People with congenital diseases are given special conditions. In essence, most of them can be vaccinated under certain conditions, including vaccination of patients with chronic kidney disease (CKD). There is a lot of news, especially on social media, about events related to vaccination. Most of the news is difficult to analyze because the information is incomplete and tends to be bombastic. So, as an effort to anticipate PIFE (post-immunization follow-up events), the side effects of Covid-19 vaccination need to be known, especially regarding CKD. This study needs to be carried out while waiting for comprehensive research on PIFE from various types of Covid-19 vaccines in CKD patients.

Accelerating National Research in 2022

We have just left 2021 and entered 2022. We all hope that the Covid-19 pandemic can be more under control, the economy grows evenly, and we can achieve progress in all fields. We also hope that academics and scientists will continue to conduct research in all fields to catch up with the progress that we have not yet achieved. Research is the foundation of a nation's progress, and one of the benchmarks for research progress is the achievement of the Nobel Prize. The Nobel Prize is a great honor for scientists, writers and humanitarian fighters. So far, the Nobel prizes for the fields of Physics, Chemistry, Biology, Medicine and Economics have always been dominated by scientists from European countries and the United States (US). Only recently have scientists from developed Asian countries such as Japan, South Korea or Israel won the Nobel Prize as well.

Memasuki 2022 dengan Memacu Riset Nasional

BARU saja kita meninggalkan 2021 dan memasuki 2022. Kita semua berharap semoga pandemi covid-19 bisa semakin terkendali, ekonomi tumbuh merata, dan kita raih kemajuan di semua bidang. Kita juga berharap agar para akademisi dan ilmuwan terus melakukan riset di segala bidang untuk mengatasi ketertinggalan kita.  Riset ialah fondasi kemajuan bangsa dan salah satu benchmark kemajuan riset ialah pencapaian hadiah Nobel. Meraih hadiah Nobel ialah kehormatan besar bagi ilmuwan, satrawan, dan pejuang kemanusiaan. Sejauh ini, untuk penghargaan Nobel untuk bidang fisika, kimia, biologi, kedokteran, dan ekonomi selalu didominasi ilmuwan dari negara-negara Eropa dan Amerika Serikat (AS). Baru belakangan, mulai disusul ilmuwan dari negara Asia yang maju, seperti Jepang, Korea Selatan (Korsel), atau Israel.